Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents,申请号US19870127831-传众专利搜索

首页产品黄页商标征信

会员服务注册登录

法人/股东/高管

发明名称	Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
摘要
申请公布号	US4791125(A)	申请公布日期	1988.12.13
申请号	US19870127831	申请日期	1987.12.02
申请人	PFIZER INC.	发明人	CLARK, DAVID A.
分类号	A61K31/425;A61P3/08;A61P9/10;C07D417/06;(IPC1-7):C07D491/052	主分类号	A61K31/425
代理机构		代理人
主权项
地址

您可能感兴趣的专利

ADAMANTYL PYRROLIDIN-2-ONE AND PIPERIDINE-2-ONE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS

BICYCLIC INHIBITORS OF HORMONE SENSITIVE LIPASE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

PYRAZOLE DERIVATIVES AND PROCESS FOR THE PRODUCTION THEREOF

Verfahren und Vorrichtung zum Sichern eines Reifens auf einer Felge

1-(4-PIPERIDINYL) BENZIMIDAZOLE DERIVATIVES USEFUL AS HISTAMINE H3 ANTAGONISTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

Zusatzeinrichtung für eine Kettensäge zur gleichzeitigen Verwendung der Kettensäge als Heckenschere

Einbruchhemmende Vorrichtung für Fenster und Türen

AN APPARATUS FOR OPERATING A COMPUTER USING THOUGHTS OR FACIAL IMPRESSIONS

APPARATUS AND METHOD FOR SURFACE COOLING

CONTROLLED RELEASE COMPOSITIONS FOR INTERFERON BASED ON PEGT-PBT BLOCK COPOLYMERS

READOUT ELECTRONICS FOR PHOTON COUNTING AND ENERGY DISCRIMINATING DETECTORS

NANOPARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS TO THE LUNG

HARNESS FOR STRETCHING THE PENIS

ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB

IL-1 RECEPTOR BASED ANTAGONISTS AND METHODS OF MAKING THEM AND REAGENTS FOR USE THEREIN

FLEXIBLE ASSEMBLY OF RECUPERATOR FOR COMBUSTION TURBINE EXHAUST

NUCLEIC ACIDS ENCODING ANTHELMINTIC AGENTS AND PLANTS MADE THEREFORM

INDOL-3-YLIDENE-HYDRAZINO-BIPHENYL- CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR MODULATING THROMBOPOIETIN ACTIVITY

IMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION , MEDICAMENTS CONTAINING THEM AND USE THEREOF FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT AND PREVENTION OF mGlu5 RECEPTOR MEDIATED DISORDERS